Paper39239559
Integrins in cancer stem cells.
Gou S and 2 others. Front Cell Dev Biol, 2024. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Integrins in cancer stem cells. Papers, record 39239559. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39239559
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References168
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19588168 | Integrin-mediated adhesion and stem-cell-niche interactions. | Cell Tissue Res | 2010 | https://conductscience.org/library/papers/19588168 | PubMed |
| 2 | 30817927 | Integrin signaling and mechanotransduction in regulation of somatic stem cells. | Exp Cell Res | 2019 | https://conductscience.org/library/papers/30817927 | PubMed |
| 3 | 31263095 | IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31263095 | PubMed |
| 4 | 21838596 | Integrin α3β1 as a breast cancer target. | Expert Opin Ther Targets | 2011 | https://conductscience.org/library/papers/21838596 | PubMed |
| 5 | 23604127 | Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis. | Oncogene | 2014 | https://conductscience.org/library/papers/23604127 | PubMed |
| 6 | 30892939 | Integrin-α7 signaling regulates connexin 43, M-cadherin, and myoblast fusion. | Am J Physiol Cell Physiol | 2019 | https://conductscience.org/library/papers/30892939 | PubMed |
| 7 | 21996747 | CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. | Oncogene | 2012 | https://conductscience.org/library/papers/21996747 | PubMed |
| 8 | 37834343 | Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834343 | PubMed |
| 9 | 29198914 | Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. | Cancer Cell | 2017 | https://conductscience.org/library/papers/29198914 | PubMed |
| 10 | 12471617 | Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion. | Int J Cancer | 2003 | https://conductscience.org/library/papers/12471617 | PubMed |
| 11 | 30889378 | Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance. | Cancer Cell | 2019 | https://conductscience.org/library/papers/30889378 | PubMed |
| 12 | 23708747 | CD49f-positive cell population efficiently enriches colon cancer-initiating cells. | Int J Oncol | 2013 | https://conductscience.org/library/papers/23708747 | PubMed |
| 13 | 34205341 | Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34205341 | PubMed |
| 14 | 30627776 | Blockade of integrin β3 signals to reverse the stem-like phenotype and drug resistance in melanoma. | Cancer Chemother Pharmacol | 2019 | https://conductscience.org/library/papers/30627776 | PubMed |
| 15 | 36219689 | Targeting integrin α2 as potential strategy for radiochemosensitization of glioblastoma. | Neuro Oncol | 2023 | https://conductscience.org/library/papers/36219689 | PubMed |
| 16 | 35561877 | LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis. | Cancer Lett | 2022 | https://conductscience.org/library/papers/35561877 | PubMed |
| 17 | 32323968 | Cell-Cell Adhesion-Driven Contact Guidance and Its Effect on Human Mesenchymal Stem Cell Differentiation. | ACS Appl Mater Interfaces | 2020 | https://conductscience.org/library/papers/32323968 | PubMed |
| 18 | 34805482 | Advancing cell instructive biomaterials through increased understanding of cell receptor spacing and material surface functionalization. | Regen Eng Transl Med | 2021 | https://conductscience.org/library/papers/34805482 | PubMed |
| 19 | 31789398 | Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma. | Int J Oncol | 2020 | https://conductscience.org/library/papers/31789398 | PubMed |
| 20 | 27765911 | Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27765911 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41942631 | Stress-responsive membrane proteins as execution nodes of tumor cell adaptation to microenvironmental stress. | Oncogene | 2026 | https://conductscience.org/library/papers/41942631 | PubMed |
| 41888835 | Integrins in cancer: insights into mechanisms and therapeutic potential. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41888835 | PubMed |
| 41683993 | Mesenchymal Stem Cell-Derived Exosomes Reprogram Chemosensitivity Pathways in Cervical Cancer Spheroids. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683993 | PubMed |
| 41601637 | Dual function antibody targeting αvβ3 and PD-L1 provide a promising strategy for solid tumor therapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/41601637 | PubMed |
| 41309738 | Transfer learning with multiomics integration and deep neural networks reveals drug resistance mechanisms in cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/41309738 | PubMed |
| 40771808 | Targeting CSC-immune cell crosstalk to overcome chemoresistance and enhance immunotherapy efficacy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40771808 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39239559
GET https://conductscience.org/api/papers/v1/39239559/references?page=2